September 7, 2026

Axsome Therapeutics (AXSM) Investor Outlook: Unveiling a 38% Upside Potential Amidst Rapid Growth in CNS Therapies

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a pioneering biopharmaceutical company, continues to capture the attention of investors with its robust growth trajectory in the healthcare sector, specifically..

Legend Biotech Corporation (LEGN): Investor Outlook on a Biotech Powerhouse with a 128.84% Upside Potential

Legend Biotech Corporation (NASDAQ: LEGN) is making waves in the biotechnology sector, with a compelling narrative that positions it as a formidable player in the cell..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Unveiling a 7.47% Potential Upside with Promising Genetic Medicine Innovations

Krystal Biotech, Inc. (NASDAQ: KRYS) has emerged as a formidable player in the biotechnology sector, focusing on the development and commercialization of genetic medicines aimed at..

RadNet, Inc. (RDNT) Stock Analysis: Exploring a Potential 28.37% Upside with Strong Buy Ratings

For investors seeking opportunities in the healthcare sector, RadNet, Inc. (NASDAQ: RDNT) presents an intriguing proposition. With a market capitalization of $5.8 billion, RadNet is a..

Nuvalent, Inc. (NUVL) Stock Analysis: What Investors Need to Know About This $9.81 Billion Biotech Player

Nuvalent, Inc. (NASDAQ: NUVL) is carving out its niche in the competitive biotechnology sector with a strong focus on developing innovative cancer therapies. With a market..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unlocking 21% Potential Upside for Healthcare Investors

Stevanato Group S.p.A. (NYSE: STVN), an Italian powerhouse in the healthcare sector, presents a compelling opportunity for investors with its diverse array of offerings in the..

Genmab A/S (GMAB) Stock Analysis: Unveiling a 15.58% Potential Upside in Biotechnology

For investors seeking promising opportunities in the biotechnology sector, Genmab A/S (NASDAQ: GMAB) stands out with its robust portfolio and promising growth trajectory. Based out of..

TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Buy Ratings and 8.14% Upside Potential

TransMedics Group, Inc. (NASDAQ: TMDX) stands out in the healthcare sector, specifically within the medical devices industry, for its innovative contributions to organ transplant therapy. With..

Alcon Inc. (ALC) Stock Analysis: Exploring a Promising 20.91% Upside Potential

Alcon Inc. (NYSE: ALC), a global leader in eye care, is catching the attention of investors with a notable 20.91% potential upside. Operating in the healthcare..

Vaxcyte, Inc. (PCVX) Stock Analysis: Examining a Potential 78% Upside in the Biotech Frontier

Vaxcyte, Inc. (NASDAQ: PCVX), a pioneering player in the biotechnology sector, stands at the forefront of vaccine innovation, with a market capitalization of $9.1 billion. Specializing..

HealthEquity, Inc. (HQY) Investor Outlook: Analyst Ratings Signal a Promising 23.87% Potential Upside

HealthEquity, Inc. (HQY), a prominent player in the healthcare information services sector, is capturing the attention of investors with its robust growth metrics and impressive analyst..

Corcept Therapeutics (CORT): Exploring the 26% Upside Potential in the Biotech Sector

Corcept Therapeutics Incorporated (CORT) is drawing significant attention in the biotech investment landscape with its compelling growth potential and strategic positioning. As a biopharmaceutical company operating..

BioNTech SE (BNTX) Stock Analysis: Navigating Growth Amidst a 15.99% Upside Potential

BioNTech SE (NASDAQ: BNTX), a stalwart in the biotechnology sector, has been at the forefront of developing innovative immunotherapies. Known primarily for its mRNA-based COVID-19 vaccine,..

Agilent Technologies, Inc. (A) Investor Outlook: Analyzing a 16.30% Potential Upside in the Diagnostics Sector

Agilent Technologies, Inc. (NYSE: A) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

AstraZeneca PLC (AZN) Stock Analysis: Unpacking a 30% Potential Upside with Strong Buy Ratings

AstraZeneca PLC (AZN), a leading giant in the healthcare sector, has been catching the eye of investors with its promising potential upside of 30.63%. As a..

AptarGroup, Inc. (ATR) Stock Analysis: A 33.54% Potential Upside Beckons Investors

AptarGroup, Inc. (NYSE: ATR), a key player in the healthcare sector, is garnering significant attention from investors looking to capitalize on its promising growth potential. With..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings and a 17.28% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a leading player in the biotechnology sector, is making waves in the healthcare industry with its robust portfolio of pharmaceutical products..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Growth Potential with a 17.97% Return on Equity

Inspire Medical Systems, Inc. (NASDAQ: INSP), a notable player in the healthcare sector, specializes in pioneering medical devices designed to tackle obstructive sleep apnea (OSA). With..

Guardant Health, Inc. (GH) Stock Analysis: Unveiling a 20% Potential Upside with Strong Buy Ratings

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, is making waves in the healthcare sector with its innovative diagnostics and research solutions. Based in..

iRhythm Holdings, Inc. (IRTC): Analyst Ratings Signal a Promising 43% Upside for Investors

iRhythm Holdings, Inc. (NASDAQ: IRTC) is capturing investor attention with its robust growth potential in the healthcare sector, specifically within the medical devices industry. The San..

Search

Funds

September 7, 2026

Search

Funds

September 7, 2026

FTSE 100

Funds